AbbVie Fights IRS Nix Of Deduction For $1.6B Merger Fee
Pharmaceutical giant AbbVie is challenging the IRS' denial of its claimed deduction for a $1.6 billion break fee payment to Irish biotechnology company Shire over their failed merger, telling the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article